Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-28

Clinical Trial Update: Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 efficacy trial comparing sertindole to a comparator in people with schizophrenia to assess cognitive effects has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sertindole (sertindole)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia, Cognition | Phase 3 | Status: COMPLETED